Cartesian Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2024-07-17: Federal exemption Rule 506(b); Types of securities offered Equity; common stock and convertible preferred stock convertible into common stock; Date of first sale 2024-07-02; Total offering amount $130,023,000.
- 2023-12-04: Federal exemption Rule 506(b); Types of securities offered convertible preferred stock convertible into common stock; Date of first sale 2023-11-13; Total offering amount $60,250,000.
- 2023-12-01: Federal exemption Rule 506(b); Types of securities offered convertible preferred stock convertible into common stock; Date of first sale 2023-11-13; Total offering amount $60,250,000.
- 2020-01-02: Federal exemption Rule 506(b); Types of securities offered Equity; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2019-12-18; Total offering amount $70,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2024-07-17 | Rule 506(b) | Equity; common stock and convertible preferred stock convertible into common stock | 2024-07-02 | $130,023,000 | $130,023,000 | $0 | 22 |
| 2023-12-04 D/A | Rule 506(b) | convertible preferred stock convertible into common stock | 2023-11-13 | $60,250,000 | $60,250,000 | $0 | 2 |
| 2023-12-01 | Rule 506(b) | convertible preferred stock convertible into common stock | 2023-11-13 | $60,250,000 | $60,250,000 | $0 | 2 |
| 2020-01-02 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2019-12-18 | $70,000,000 | $70,000,000 | $0 | 26 |
| 2017-07-11 | Rule 506(b) | Equity; OptionToAcquire; SecurityToBeAcquired | 2017-06-27 | $50,000,000 | $50,000,000 | $0 | 11 |
| 2015-09-10 | Rule 506(b) | Equity; OptionToAcquire | 2015-08-27 | $40,637,943 | $37,400,000 | $3,237,943 | 19 |
| 2015-04-23 | Rule 506(b) | Debt; OptionToAcquire | 2015-04-10 | $7,500,000 | $5,942,306 | $1,557,694 | 12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |